Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-15-000227
Filing Date
2015-02-13
Accepted
2015-02-13 17:14:45
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-Q aeolus10q.htm 10-Q 475818
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 14520
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 14871
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 8792
  Complete submission text file 0001102624-15-000227.txt   2945928

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20141231.xml EX-101.INS 356261
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20141231.xsd EX-101.SCH 29991
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20141231_cal.xml EX-101.CAL 23995
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20141231_def.xml EX-101.DEF 92245
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20141231_lab.xml EX-101.LAB 227165
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20141231_pre.xml EX-101.PRE 154940
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 15616244
SIC: 2834 Pharmaceutical Preparations